关注
David Frame
David Frame
在 med.umich.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Tocilizumab for treatment of mechanically ventilated patients with COVID-19
EC Somers, GA Eschenauer, JP Troost, JL Golob, TN Gandhi, L Wang, ...
Clinical Infectious Diseases 73 (2), e445-e454, 2021
5202021
Spontaneous apoptosis of endometrial tissue is impaired in women with endometriosis
HM Gebel, DP Braun, A Tambur, D Frame, N Rana, WP Dmowski
Fertility and sterility 69 (6), 1042-1047, 1998
3581998
Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant
MR Savona, D Newton, D Frame, JE Levine, S Mineishi, DR Kaul
Bone marrow transplantation 39 (12), 783-787, 2007
1412007
Engraftment syndrome after allogeneic hematopoietic cell transplantation predicts poor outcomes
L Chang, D Frame, T Braun, E Gatza, DA Hanauer, S Zhao, JM Magenau, ...
Biology of Blood and Marrow Transplantation 20 (9), 1407-1417, 2014
1032014
Efficacy of ondansetron and prochlorperazine for the prevention of postoperative nausea and vomiting after total hip replacement or total knee replacement procedures: a …
JJ Chen, DG Frame, TJ White
Archives of internal medicine 158 (19), 2124-2128, 1998
791998
Selective cyclooxygenase‐2 inhibition: a target in cancer prevention and treatment
S Subongkot, D Frame, W Leslie, D Drajer
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 23 (1), 9-28, 2003
722003
Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies
J Magenau, H Tobai, A Pawarode, T Braun, E Peres, P Reddy, C Kitko, ...
Blood, The Journal of the American Society of Hematology 118 (15), 4258-4264, 2011
602011
Hematologic manifestations of deficiency of adenosine deaminase 2 (DADA2) and response to tumor necrosis factor inhibition in DADA2-associated bone marrow failure
TF Michniacki, M Hannibal, CW Ross, DG Frame, AS DuVall, R Khoriaty, ...
Journal of Clinical Immunology 38, 166-173, 2018
592018
Baseline body mass index among children and adults undergoing allogeneic hematopoietic cell transplantation: clinical characteristics and outcomes
M Gleimer, Y Li, L Chang, S Paczesny, DA Hanauer, DG Frame, ...
Bone marrow transplantation 50 (3), 402-410, 2015
502015
Risk factors for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients
AM Huang, BL Marini, D Frame, DM Aronoff, JL Nagel
Transplant Infectious Disease 16 (5), 744-750, 2014
392014
Intravesicular instillation of E-aminocaproic acid for patients with adenovirus-induced hemorrhagic cystitis
A Lakhani, A Raptis, D Frame, D Simpson, L Berkahn, S Mellon-Reppen, ...
Bone marrow transplantation 24 (11), 1259-1260, 1999
381999
Treatment of dyslipidemia in allogeneic hematopoietic stem cell transplant patients
BL Marini, SW Choi, CA Byersdorfer, S Cronin, DG Frame
Biology of Blood and Marrow Transplantation 21 (5), 809-820, 2015
362015
New strategies in controlling drug resistance
D Frame
Journal of Managed Care Pharmacy 13 (8 Supp A), 13-17, 2007
362007
Best practice management of CINV in oncology patients: I. Physiology and treatment of CINV. Multiple neurotransmitters and receptors and the need for combination therapeutic …
DG Frame
The journal of supportive oncology 8 (2 Suppl 1), 5-9, 2010
332010
Systemic absorption of oral vancomycin in a peripheral blood stem cell transplant patient with severe graft‐versus‐host disease of the gastrointestinal tract
JM Pogue, DD DePestel, DR Kaul, Y Khaled, DG Frame
Transplant Infectious Disease 11 (5), 467-470, 2009
322009
A digital protein microarray for COVID-19 cytokine storm monitoring
Y Song, Y Ye, SH Su, A Stephens, T Cai, MT Chung, MK Han, ...
Lab on a Chip 21 (2), 331-343, 2021
312021
Central nervous system complications of hematopoietic stem cell transplant
FI Syed, DR Couriel, D Frame, A Srinivasan
Hematology/Oncology Clinics 30 (4), 887-898, 2016
302016
Effect of renal function on the pharmacokinetics of valsartan
P Prasad, S Mangat, L Choi, S Chen, B Chen, A Bernardo, D Frame, ...
Clinical drug investigation 13, 207-214, 1997
281997
Maintenance sorafenib in FLT3-ITD AML following allogeneic HCT favorably impacts relapse and overall survival
G Chappell, M Geer, E Gatza, T Braun, T Churay, J Brisson, D Bixby, ...
Bone Marrow Transplantation 54 (9), 1518-1520, 2019
242019
Impact of COVID-19 on pediatric immunocompromised patients
JA Connelly, H Chong, AJ Esbenshade, D Frame, C Failing, E Secord, ...
Pediatric Clinics 68 (5), 1029-1054, 2021
222021
系统目前无法执行此操作,请稍后再试。
文章 1–20